Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 29:8:503.
doi: 10.1186/s13104-015-1452-x.

Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia

Affiliations

Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia

Gebrehiwet Tesfahuneygn et al. BMC Res Notes. .

Abstract

Background: Non-adherence to tuberculosis (TB) treatment can result in an emergence of new strains, prolonged infectiousness, drug resistance and poor treatment outcomes. Thus, assessment of the level of adherence to anti-TB treatment, treatment outcomes and identifying factors associated with non-adherence and poor treatment outcomes are vital for improving TB treatment adherence and treatment outcomes in the study area. The main objectives of the current study were to assess the level of adherence to anti-TB treatment among patients taking anti-TB drug treatment and to identify factors associated with non-adherence. Whereas, the secondary objectives were to assess treatment outcomes and factors associated with poor treatment outcomes among TB patients previously treated at the health institutions of Alamata District, northeast Ethiopia.

Methods: In a health facility-based cross-sectional study, TB patients who were taking anti-TB drug treatment were interviewed using a structured questionnaire to evaluate level of adherence to anti-TB treatment. TB treatment outcomes were evaluated using data generated from a record review of previous TB patients who were treated at health facilities of Alamata District from January 2007 to June 2012. Adherence data and treatment outcomes data were computerized separately using Epi-Data version 3.1 and analyzed using STATA version 10.0.

Results: Between November 2012 and January 2013, 116 (58.0%) male TB patients and 84 (42.0%) female TB patients were interviewed, of whom 77.5% were new cases, 23.5% were smear-positive pulmonary TB (SPPTB) cases, 26.5% were smear-negative PTB (SNPTB) cases and 50.0% were extra pulmonary (EPTB) cases. The overall adherence rate to anti-TB treatment was 88.5%. The main reasons for the non-adherent patients were forgetting to take medication, being away from home, drug side effects, being unable to go to the health facilities on the date of appointment and being hospitalized. In the TB treatment outcomes component of the current study, records of 4,275 TB patients were reviewed and the overall treatment success rate was 90.1%. Two-hundred fifteen (5.0%) patients had unsuccessful treatment outcomes, of whom 76 (35.3%) defaulted, 126 (58.6%) died and 13 (6.1%) had treatment failure. Significant predictors of unsuccessful treatment outcomes were being positive for human immunodeficiency virus (HIV) infection [adjusted odds ratio (aOR) = 2.1, 95% CI 1.5-3.0], being SPPTB case (aOR = 3.4, 95% CI 2.4-4.8), being SNPTB case (aOR = 2.0, 95% CI 1.5-2.8)], and being re-treatment cases (aOR = 2.6, 95% CI 1.5-3.7).

Conclusion: In the present study area, there was a high level of adherence to anti-TB treatment and also a high TB treatment success rate. However, still further effort like health education to patient or family is needed to reduce those factors which affect adherence and treatment success rates in order to ensure higher rates of adherence and treatment success than the currently observed in the present study area.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Adherence (expressed in percent) across health facilities in Alamata District. Adherence was measured by self-report and it is based on the ratio of the number of doses taken as per instruction divided by the number of dose prescribed over the last 30 days
Fig. 2
Fig. 2
Treatment outcomes (expressed in percent) among health facilities. This shows variations in treatment outcomes across health facilities in the study district

References

    1. WHO . Global tuberculosis report 2012. WHO/HTM/TB/2012,6. Geneva: Switzerland; 2012.
    1. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Syst Rev. 2007;17:CD003343. - PubMed
    1. Dooley KE, Lahlou O, Ghali I, Knudsen J, Elmessaoudi D, Cherkaoui I, Aouad RE. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Publ Health. 2011;11:140. doi: 10.1186/1471-2458-11-140. - DOI - PMC - PubMed
    1. Charles P. Felton National Tuberculosis Center. Adherence to Treatment for Latent Tuberculosis Infection. A Manual for Health Care Providers. 2005.
    1. Franke F, Appleton C, Arteaga F, Palacios E, Llaro K, Shin S, Becerra C, Murray B, Mitnick D. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008;46:1844–1851. doi: 10.1086/588292. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources